There is a wave of "restriction on purchases" in the public offering market. The announcement of Huitianfu Fund on December 11th shows that since December 12th, Huitianfu Enhanced Income Bond A has suspended large-scale subscription, large-scale conversion and large-scale fixed investment business, and the amount of single or multiple cumulative subscriptions, conversion and fixed investment in a single fund account per day should not exceed 10 million yuan (inclusive). Recently, the reporter found that there is a "restricted purchase tide" in the public offering market. Whether it is active equity funds, bond funds or QDII funds, many outstanding products have recently announced the suspension of large-scale subscription, and even QDII products have directly "closed the market" and suspended all buying operations. (CSI)Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Vietnam Customs: The export volume of rice in November was 704,608 tons.
China Securities Index Company released two free cash flow indices today, and China Securities Index Company officially released two stock strategy indices, namely, CSI Free Cash Flow Index and CSI 800 Free Cash Flow Index. CSI Free Cash Flow Index Series selects the securities with high free cash flow rate as the index sample on the basis of fully investigating the cash flow ability and financial health of enterprises, which has the characteristics of good index return performance and outstanding defensive attributes. CSI Index Company continuously enriches the strategic index system based on dividend, cash flow, value, growth, quality and other factors, and continuously improves the supply of strategic indexes with differentiated risk-return characteristics. By the end of November this year, more than 300 stock strategy indexes had been released, and the scale of tracked products exceeded 100 billion yuan.Local regulators have found out the situation of institutions purchasing unlicensed financial information service products. The reporter was informed that some local securities regulatory bureaus are finding out the situation of institutions purchasing unlicensed financial information service products. The regulatory requirements require the securities fund and futures-related operating institutions within their jurisdiction to self-inspect the purchase of foreign financial information service products without the permission of the National Network Information Office. The main contents include a brief description of financial information service products, the contact telephone number and email address of foreign institutions, and so on. According to relevant regulations, the provision of financial information services by foreign institutions in China must be approved. Up to now, a total of 31 foreign institutions and 10 enterprises invested and established by foreign institutions in China have been licensed to provide financial information services. (Cailian)Volvo Cars: The Daqing plant has rolled off 500,000 vehicles.
State Railway Administration: From January to November, the national railway passenger volume reached a record high, and the State Railway Administration announced that from January to November, the national railway passenger volume reached a record high. From January to November, the number of railway passengers sent nationwide reached 4.015 billion, up 12.6% year-on-year, and the annual number of passengers sent exceeded 4 billion for the first time, reaching a record high. Passenger turnover reached 1,484.061 billion person-kilometers, a year-on-year increase of 7.8%. In the month of November, the number of railway passengers sent nationwide was 304 million, up 8.8% year-on-year; Passenger turnover reached 98.135 billion person-kilometers, a year-on-year increase of 2.5%. The volume of freight delivery has increased steadily. From January to November, the national railway freight volume was 4.715 billion tons, a year-on-year increase of 2.5%. In November, the national railway freight volume was 455 million tons, a year-on-year increase of 6.4%; The freight turnover was 324.521 billion tons kilometers, up 2.4% year-on-year.It is reported that the Bank of Japan believes that the cost of waiting for the next rate hike is not great, and the short-term earthquake of the yen market is reported. It is reported that the Bank of Japan believes that the cost of waiting for the next rate hike is not great. Some policy makers are not opposed to raising interest rates in December if it is proposed. It is said that officials believe that the next rate hike is only a matter of time, not whether to raise interest rates. In addition, they believe that there is little risk that the depreciation of the yen will push up inflationary pressure at this stage. The yen then fluctuated greatly. USD/JPY once fell to a low of 150.99, then rose by about 100 points, and now it is back to around 152. Judging from the current situation, traders expect the probability that the Bank of Japan will raise interest rates by 25 basis points next week to be around 26%.The Shanghai Municipal Science and Technology Commission issued the Action Plan for Promoting the Innovative Development of Scientific Instruments and Reagents in Shanghai (2025-2027), which was formulated by the Shanghai Municipal Science and Technology Commission to promote the innovative development of the scientific instruments and reagents industry in Shanghai. Adhere to the working idea of "following the development law, facing the needs of the industry, strengthening superior products, cultivating and expanding enterprises, and creating a development ecology", adhere to the product as the traction, strengthen key core technology research, vigorously cultivate first-class enterprises, and promote the high-quality development of the industry. By 2027, 1-2 technical test and verification platforms will be built, and more than 5 application scenarios and user experience centers will be built. The scientific and technological innovation ability of scientific instruments and scientific research reagents in our city will be further enhanced, and the industrial innovation ecology will be further improved. More than 5 leading scientific and technological enterprises in subdivided tracks will be cultivated, and more than 5 scientific instruments and 10 scientific research reagents reaching the international leading level will be formed. The industrial output value of scientific instruments and scientific research reagents will be about 45 billion yuan.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide